Rocuronium
Breast-Conserving Surgery
Jun ZhangN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Breast-Conserving Surgery cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
RAMIFENTANYL Jun Zhang | N/A | D |
Cefazolin Fabiola Soares Moreira Campos | N/A | D |
SUFENTANYL Jun Zhang | N/A | D |
ROPIVACAINE Jun Zhang | N/A | D |
MIDAZOLAM Jun Zhang | N/A | D |
PROPOFOL Jun Zhang | N/A | D |
Same molecule, other indications
Rocuronium is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →